These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27313747)

  • 1. Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma.
    Ning XH; Li T; Gong YQ; He Q; Shen QI; Peng SH; Wang JY; Chen JC; Guo YL; Gong K
    Oncol Lett; 2016 Jun; 11(6):4095-4098. PubMed ID: 27313747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K; Zhang N; Zhang K; Na Y
    Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose 1,6-Bisphosphatase 1 Expression Reduces
    Chen R; Zhou X; Huang G; Liu J
    Contrast Media Mol Imaging; 2019; 2019():9463926. PubMed ID: 30723389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBP1 expression is associated with basal-like breast carcinoma.
    Shi L; Zhao C; Pu H; Zhang Q
    Oncol Lett; 2017 May; 13(5):3046-3056. PubMed ID: 28529559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
    Shi L; He C; Li Z; Wang Z; Zhang Q
    Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose-1,6-bisphosphatase opposes renal carcinoma progression.
    Li B; Qiu B; Lee DS; Walton ZE; Ochocki JD; Mathew LK; Mancuso A; Gade TP; Keith B; Nissim I; Simon MC
    Nature; 2014 Sep; 513(7517):251-5. PubMed ID: 25043030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
    Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
    Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.
    Kroeger N; Seligson DB; Signoretti S; Yu H; Magyar CE; Huang J; Belldegrun AS; Pantuck AJ
    Eur J Cancer; 2014 May; 50(8):1531-40. PubMed ID: 24565854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma.
    Kampantais S; Kotoula V; Kounatidis I; Vakalopoulos I; Gourvas V; Lymperi S; Dimitriadis G
    Mol Clin Oncol; 2020 Sep; 13(3):11. PubMed ID: 32754325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
    Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients.
    Kroeze SG; Vermaat JS; van Brussel A; van Melick HH; Voest EE; Jonges TG; van Diest PJ; Hinrichs J; Bosch JL; Jans JJ
    Eur J Cancer; 2010 Dec; 46(18):3375-82. PubMed ID: 20709525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.
    Xu J; Wang B; Xu Y; Sun L; Tian W; Shukla D; Barod R; Grillari J; Grillari-Voglauer R; Maxwell PH; Esteban MA
    Oncogene; 2012 Feb; 31(8):1065-72. PubMed ID: 21841824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation.
    Yeo EJ; Cho YS; Kim MS; Park JW
    Ann Hematol; 2008 Jan; 87(1):11-7. PubMed ID: 17712557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.